(Q43687605)

English

Non-obese diabetic (NOD) mice exhibit an increased cellular immune response to glycated-LDL but are resistant to high fat diet induced atherosclerosis

scientific article published in August 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Non-obese diabetic (NOD) mice exhibit an increased cellular immune response to glycated-LDL but are resistant to high fat diet induced atherosclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

atherosclerosis

1 reference

based on heuristic

inferred from title

2

object named as

George J

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

Keren P

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Keren G

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Harats D

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

157

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

285-292

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

The oxidation hypothesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900685-7

7 January 2021

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900685-7

7 January 2021

Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900685-7

7 January 2021

Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900685-7

7 January 2021

Immune response to glycated and oxidized LDL in IDDM patients with and without renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900685-7

7 January 2021

Increased atherosclerosis in streptozotocin-induced diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900685-7

7 January 2021

Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900685-7

7 January 2021

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900685-7

7 January 2021

Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900685-7

7 January 2021

Continuous monitoring of in vitro oxidation of human low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900685-7

7 January 2021

Oxidized low-density lipoprotein (Ox-LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS).

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900685-7

7 January 2021

Quantitative assessment of atherosclerotic lesions in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900685-7

7 January 2021

Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900685-7

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900685-7

7 January 2021

Glycated low-density lipoprotein and atherogenesis: the missing link between diabetes mellitus and hypercholesterolaemia?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900685-7

7 January 2021

Advanced glycation end products, oxidant stress and vascular lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900685-7

7 January 2021

Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900685-7

7 January 2021

Non-enzymatic glycation of apolipoprotein B in the sera of diabetic and non-diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900685-7

7 January 2021

Is atherosclerosis an immunologically mediated disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900685-7

7 January 2021

Identifiers

10.1016/S0021-9150(00)00685-7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

release_bow2tgdthvafhimryrxadag7pe

1 reference

https://api.fatcat.wiki/v0/release/bow2tgdthvafhimryrxadag7pe

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43687605&oldid=2102513993"